title: [Revolutionizing HIV-therapy by Tre-Recombinase? Initial observations and current state of development].
authors: Heinrich-Pette-lnstitut - Leibniz-lnstitut für Experimentelle Virologie, Hamburg. joachim.hauber@hpi-uni-hamburg.de
authors: Joachim
authors: J
authors: Hauber
authors: Ilona
authors: I
authors: Hauber
authors: Frank
authors: F
authors: Buchholz
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D015507:Drugs, Investigational / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D019426:Integrases / Q000627:therapeutic use*; D051379:Mice; D058990:Molecular Targeted Therapy; D011533:Proviruses / Q000187:drug effects*
chemical_list: D019380:Anti-HIV Agents; D015507:Drugs, Investigational; C045073:Cre recombinase; D019426:Integrases; C583669:Tre-Recombinase